Uppsala, Sweden

Lidds Ab

USPTO Granted Patents = 8

% Expired Patents = 25.0



Trademarks = 1

Forward Citations = 61

Loading Chart...
Loading Chart...

10 inventors (with patents filed for the assignee):

goldMedal Niklas Axén (8 out of 12 patents)

silverMedal Hans Lennernäs (6 out of 13 patents)

bronzeMedal Bo Lennernäs (3 out of 6 patents)

4.  Jonas Hugosson (3 out of 3 patents)

5.  Stefan Gruden (2 out of 2 patents)

6.  Lars Åke Malmsten (2 out of 2 patents)

7.  Anders Carlsson (1 out of 22 patents)

8.  Johan Yngve (1 out of 1 patent)

9.  Gunilla Eketorp (1 out of 1 patent)

10.  Åke G Pilbrant (1 out of 1 patent)

11.  Niklas Axen (5 patents)

12.  Ake G Pilbrant (2 patents)

13.  Anders Carlsson (0 patent)

14.  Hans Lennernas (0 patent)

15.  Hans Lennernaes (0 patent)


8 patents:

Company Overview
LIDDS AB is a Swedish drug delivery company focused on development of innovative pharmaceutical products for the treatment of cancer. Their patented NanoZolid technology enables controlled and sustained release of active substances, resulting in enhanced efficacy and reduced side effects.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

8 Patents

#39 in Uppsala

#720 in Sweden

Uppsala, SE
Uppsala, Sweden
Forward Citations = 61

10 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Lidds Ab. Retrieved from https://idiyas.com/company/lidds-ab

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…